| 000 | 01733 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250517120109.0 | ||
| 264 | 0 | _c20170619 | |
| 008 | 201706s 0 0 eng d | ||
| 022 | _a1551-4005 | ||
| 024 | 7 |
_a10.1080/15384101.2016.1235104 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKwon, Minsu | |
| 245 | 0 | 0 |
_aEfficacy of poly (ADP-ribose) polymerase inhibitor olaparib against head and neck cancer cells: Predictions of drug sensitivity based on PAR-p53-NF-κB interactions. _h[electronic resource] |
| 260 |
_bCell cycle (Georgetown, Tex.) _cNov 2016 |
||
| 300 |
_a3105-3114 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aPhthalazines _xpharmacology |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aPoly Adenosine Diphosphate Ribose _xmetabolism |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 700 | 1 | _aJang, Hyejin | |
| 700 | 1 | _aKim, Eun Hye | |
| 700 | 1 | _aRoh, Jong-Lyel | |
| 773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 15 _gno. 22 _gp. 3105-3114 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/15384101.2016.1235104 _zAvailable from publisher's website |
| 999 |
_c26469659 _d26469659 |
||